Bullish option flow detected in Aurinia Pharmaceuticals with 9,672 calls trading, 12x expected, and implied vol increasing over 10 points to 90.72%. Jan-24 8 calls and Feb-24 8 calls are the most active options, with total volume in those strikes near 7,600 contracts. The Put/Call Ratio is 0.05. Earnings are expected on February 27th.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on AUPH:
- Aurinia Pharmaceuticals call volume above normal and directionally bullish
- Aurinia Pharmaceuticals sees FY24 net product revenue $200M-$220M
- Aurinia Pharmaceuticals sees FY23 revenue about $176M, consensus $174.71M
- Aurinia Pharmaceuticals sees Q4 revenue about $45M, consensus $44.2M
- Aurinia Pharmaceuticals submits IND application to FDA for AUR200